Fertility Awareness Effectiveness

Complete Cycle Mapping Using a Quantitative At-Home Hormone Monitoring System in Prediction of Fertile Days, Confirmation of Ovulation, and Screening for Ovulation Issues Preventing Conception

Wegrzynowicz AK, Beckley A, Eyvazzadeh A, Levy G, Park J, Klein J

Published December 15, 2022 Medicina (Kaunas, Lithuania)
DOI 10.3390/medicina58121853 PMID 36557055 PMC PMC9783738

RRM Academy Synopsis

At-home urine hormone test confirmed ovulation in 38 of 40 cycles

In a pilot study of 40 women who each tracked one cycle, an at-home urine hormone test confirmed ovulation in 38 of 40 cycles. The fertile window averaged 5.32 days. Only 22 of the 40 women kept progesterone-metabolite levels high through the implantation window.

Key Findings

  • A rise in PdG (the urine marker of progesterone) confirmed ovulation in 38 of the 40 cycles. The two cycles without ovulation belonged to women with a PCOS diagnosis.
  • In the 38 ovulatory cycles the fertile window, counted from the E1G rise to the PdG rise, averaged 5.32 days (95% CI 4.65 to 6.00; range 1 to 11).
  • The E1G rise came an average of 2.68 days before the LH peak, and the PdG rise followed the LH peak by an average of 2.64 days.
  • Twenty-two of the 40 cycles held PdG up on three or more of four implantation-window testing days. The remaining 16 ovulatory cycles showed low PdG, classed by the authors as ovulatory dysfunction.
  • Seventeen cycles (43%) had at least one day of elevated FSH. Ovulation Score and maximum PdG did not differ between the elevated and non-elevated FSH groups (p = 0.40 and 0.46).

Interpretation

This pilot observational study followed one cycle per woman, aged 24 to 46. The women came from the customer base of the company that makes the test. Forty percent had a known fertility issue, and fertile-window measures did not differ significantly by diagnosis or treatment. The first two authors are affiliated with MFB Fertility, the manufacturer. The outcomes were hormone readings across a cycle. The authors note that the window opens at the first E1G rise, so women with 8, 9 or 11 detected days are not fertile on every one of them.

RRM Context

Restorative reproductive medicine treats ovulation as a finding to confirm in each woman's own cycle. The authors observe that many clinicians still assume day 14 ovulation and time labs to cycle day 21, although most cycles fall outside those assumptions. In this cohort, 16 women ovulated yet showed low PdG across the implantation window. The authors conclude that confirming ovulation alone falls short of assessing ovulatory function.

Abstract

Background and Objectives

To achieve pregnancy, it is highly beneficial to identify the time of ovulation as well as the greater period of fertile days during which sperm may survive leading up to ovulation. Confirming successful ovulation is also critical to accurately diagnose ovulatory disorders. Ovulation predictor kits, fertility monitors, and tracking apps are all available to assist with detecting ovulation, but often fall short. They may not detect the full fertile window, provide accurate or real-time information, or are simply expensive and impractical. Finally, few over-the-counter products provide information to women about their ovarian reserve and future fertility. Therefore, there is a need for an easy, over-the-counter, at-home quantitative hormone monitoring system that assesses ovarian reserve, predicts the entire fertile window, and can screen for ovulatory disorders.

Materials and Methods

Proov Complete is a four-in-one at-home multihormone testing system that utilizes lateral flow assay test strips paired with the free Proov Insight App to guide testing of four hormones-FSH, E1G, LH, and PdG-across the woman's cycle. In a pilot study, 40 women (including 16 with a fertility-related diagnosis or using fertility treatments) used Complete for one cycle.

Results

Here, we demonstrate that Proov Complete can accurately and sensitively predict ovarian reserve, detect up to 6 fertile days and confirm if ovulation was successful, in one easy-to-use kit. Ovulation was confirmed in 38 cycles with a detectable PdG rise. An average of 5.3 fertile days (from E1G rise to PdG rise) were detected, with an average of 2.7 days prior to LH surge. Ovulation was confirmed via PdG rise an average of 2.6 days following the LH surge. While 38/40 women had a PdG rise, only 22 had a sustained PdG level above 5 μg/mL throughout the critical implantation window, indicating ovulatory dysfunction in 16 women.

Conclusions

Proov Complete can detect the entire fertile window of up to 6 fertile days and confirm ovulation, while also providing information on ovarian reserve and guidance to clinicians and patients.

Read the guide

  • Fertility Awareness Methods Compared

    Clinician-reviewed comparison of fertility awareness-based methods (Billings, Creighton, Sensiplan, Marquette, Standard Days, apps). Every effectiveness figure cited and labeled by metric.

    30 min read

Topics

By this author

Related research

Fertility Awareness › Effectiveness › Fertile Window Estimation · Diagnostics › Hormone Testing › Urinary Metabolites · Reproductive Endocrinology › Ovulation Physiology › Ovarian Reserve
Andrea K Wegrzynowicz, Amy Beckley, Aimee Eyvazzadeh, Gary Levy, John Park, Joshua Klein
A Wegrzynowicz, A Beckley, A Eyvazzadeh, G Levy, Jack Park, J Park, Josh Klein, J Klein
PMID 36557055 36557055 DOI 10.3390/medicina58121853 10.3390/medicina58121853 Wegrzynowicz et al. 2022, Wegrzynowicz 2022